Anticancer Drug Design Using Scaffolds of β-Lactams, Sulfonamides, Quinoline, Quinoxaline and Natural Products. Drugs Advances in Clinical Trials

Author(s): I. Balderas-Renteria, P. Gonzalez-Barranco, A. Garcia, B. K. Banik, G. Rivera

Journal Name: Current Medicinal Chemistry

Volume 19 , Issue 26 , 2012

Become EABM
Become Reviewer
Call for Editor


Eleven years after the start of a new millennium characterized by amazing scientific development, the cure for cancer remains a major challenge for humanity. In this regard, scientific efforts have focused on the search for new therapeutic targets that involve specific recognition and stop the spread of cancer cells, as well as the development of new therapeutic options that show greater specificity and better therapeutic efficacy. This review includes recent published literature about new anticancer drug design using scaffolds of β-lactams, sulfonamides, quinoline, quinoxaline and natural products, and focuses on the structure-activity relationships of scaffolds that have been reported to potently inhibit cell growth of human tumor cell lines. It describes not only those synthetic or natural compounds aimed at specific molecular targets of cancer cells in vitro, but also compounds currently in clinical trials.

Keywords: Cancer, drugs, lactams, natural products, quinoline, quinoxaline, sulfonamide, targets, clinical trials, anticancer.

Rights & PermissionsPrintExport Cite as

Article Details

Year: 2012
Published on: 23 September, 2012
Page: [4377 - 4398]
Pages: 22
DOI: 10.2174/092986712803251593
Price: $65

Article Metrics

PDF: 54